PADAGIS ISRAEL FDA Approval ANDA 215266

ANDA 215266

PADAGIS ISRAEL

FDA Drug Application

Application #215266

Application Sponsors

ANDA 215266PADAGIS ISRAEL

Marketing Status

None (Tentative Approval)001

FDA Submissions

UNKNOWN; ORIG1TA2022-10-17STANDARD

Submissions Property Types

ORIG1Null31

CDER Filings

PADAGIS ISRAEL
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 215266
            [companyName] => PADAGIS ISRAEL
            [docInserts] => ["",""]
            [products] => [{"drugName":"HALOBETASOL PROPIONATE","activeIngredients":"HALOBETASOL PROPIONATE","strength":"0.05%","dosageForm":"FOAM;TOPICAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"10\/17\/2022","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2022-10-17
        )

)

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.